The 20 Best Lung Adenocarcinoma Doctors Near Me in District of Columbia, US

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and Pleuropulmonary Blastoma. Dr. Levy is board certified in American Board Of Internal Medicine.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 61 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Chronic Lymphocytic Leukemia (CLL). Dr. Kressel is board certified in American Board Of Internal Medicine.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer. Dr. Halthore is board certified in American Board Of Radiology.

Hassan Chami is a Pulmonary Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Chami is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Large-Cell Lung Carcinoma, and EGFR Positive Lung Cancer. Dr. Chami is board certified in American Board Of Internal Medicine.

Andrew Lerner, M.D., is a clinical instructor of medicine in the pulmonary and critical care medicine department at the Johns Hopkins University School of Medicine, as well as the director of interventional pulmonology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. He practices out of Sibley Memorial Hospital in Washington, D.C. Dr. Lerner is part of the Sibley Memorial Hospital Lung Nodule and Lung Cancer Screening Clinic, the Multidisciplinary Pulmonary and Thoracic Surgery Clinic, and the Multidisciplinary Thoracic Tumor Board Conference. Dr. Lerner has an expertise in minimally invasive procedures for the early diagnosis and treatment of malignant and non-malignant diseases of the airways, lungs and pleura. He is experienced in advanced diagnostic and therapeutic bronchoscopy, including endobronchial ultrasound (EBUS) bronchoscopy, navigational bronchoscopy, rigid bronchoscopy, tumor ablative techniques, airway stent placement, airway dilation, radial EBUS, conventional transbronchial needle aspiration (TBNA), bronchial thermoplasty, whole lung lavage and percutaneous lung biopsy; as well as percutaneous tracheostomy, tunneled pleural catheter placement, thoracentesis, tube thoracoscopy, medical thoracoscopy, chemical pleurodesis and upper endoscopy (EGD/PEG) placement. Dr. Lerner earned his medical degree from George Washington University School of Medicine. He completed his residency in internal medicine at Thomas Jefferson University Hospital, followed by a fellowship in pulmonary and critical care medicine at the University of California, San Diego. Dr. Lerner then completed a two-year advanced fellowship in interventional pulmonology at The Johns Hopkins Hospital, including a chief fellowship year. He has been involved in multiple research projects in the field and completed a Science of Clinical Investigation Certificate Program at Johns Hopkins University Bloomberg School of Public Health. Dr. Lerner has been a member of the Alpha Omega Alpha medical honors society since 2011 and earned The Johns Hopkins Hospital Patient Safety Star Award in 2016. Dr. Lerner has contributed to numerous presentations, lectures, publications, book chapters and abstracts. He is a reviewer for several research journals. Dr. Lerner has various research interests and is currently involved in research projects focusing on EBUS bronchoscopy, lung cancer diagnosis and staging, and other topics. Confidential email to reach Dr. Lerner for any questions: alerner@jhu.edu. Dr. Lerner is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Lymphofollicular Hyperplasia, Pleural Effusion, Pleurisy, and Endoscopy. Dr. Lerner is board certified in American Board Of Internal Medicine.

Stephen R. Broderick, M.D., MPHS, is an assistant professor of surgery at Johns Hopkins University School of Medicine and a thoracic surgeon, part of a multidisciplinary team treating lung cancer patients in the Johns Hopkins Kimmel Cancer Center. Listen to Dr. Broderick's Cancer Matters podcast episode to learn more about his work. Dr. Broderick's primary clinical focus is at Sibley Memorial Hospital, in Washington, D.C. He also practices at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore, Maryland. Dr. Broderick has a clinical expertise in surgical treatment of lung cancer, esophageal cancer and other thoracic malignancies, as well as benign thoracic conditions. This includes achalasia, bronchoscopy, chest wall reconstruction and tumors, lung nodules and paraesophageal hernias. He has a clinical interest in minimally invasive surgery for lung cancer and the coordinated delivery of multidisciplinary care for thoracic oncology patients. Before joining Johns Hopkins, Dr. Broderick was a thoracic surgeon at St Luke’s Hospital, where he served as the medical director of the cardiothoracic intensive care unit and a member of the oncology steering committee. He also served as an instructor of surgery at Washington University School of Medicine. Dr. Broderick received his medical degree from Georgetown University School of Medicine in 2003 and he completed his internship and residency training in general surgery at New York-Presbyterian Hospital. He studied the molecular biology of lung cancer as a research fellow at Memorial Sloan Kettering Cancer Center, where he received the Chairman's Award for outstanding contributions to the basic science research fellowship. Dr. Broderick also completed a fellowship in thoracic surgery at Washington University School of Medicine in 2012 and earned a Masters in Population Health Science from Washington University School of Medicine in 2014. Dr. Broderick is a member of the American College of Chest Physicians, The Society of Thoracic Surgeons and the American Society of Clinical Oncology. Dr. Broderick’s research interests are focused on improving outcomes for lung cancer patients. He is particularly interested in studying how various treatments for early-stage lung cancer impact patients’ quality of life. Dr. Broderick has contributed to numerous publications and is a reviewer for the Journal of Cardiovascular and Thoracic Surgery, as well as Annals of Thoracic Surgery. Dr. Broderick is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Tubal Ligation, and Lung Transplant. Dr. Broderick is board certified in American Board Of Thoracic Surgery and American Board Of Surgery.

Stephen Liu is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.

Eric Anderson is an Intensive Care Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Anderson is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Endoscopy, and Advanced Bronchoscopy.

Deepa Subramaniam is an Internal Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Subramaniam is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Rebecca Krochmal is an Intensive Care Medicine provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 17 years. Dr. Krochmal is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Endoscopy, and Gastrostomy.

Irina Veytsman is a Hematologist and an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Veytsman is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.

Joshua Reuss is a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Reuss is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Pleuropulmonary Blastoma, and Tissue Biopsy.

Nitika Paudel is a Radiologist practicing medicine in Washington, Washington, D.c.. Dr. Paudel is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC).

Keith Mortman is a Thoracic Surgeon practicing medicine in Washington, Washington, D.c.. Dr. Mortman is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Lung Nodules, Thymectomy, and Endoscopy. Dr. Mortman is board certified in American Board Of Thoracic Surgery.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer. Dr. Kumar is board certified in American Board Of Radiology.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Breast Cancer, and Pancreatic Cancer. Dr. Croog is board certified in American Board Of Radiology.

Peter G. Hamm, M.D., is a pulmonologist with Johns Hopkins Medicine Pulmonology. Dr. Hamm is also the chairman of the department of medicine and the chairman of the intensive care unit (ICU) committee at Sibley Memorial Hospital. Dr. has an expertise in annual physicals, acute and urgent care, disease management and pulmonary medicine. He earned his medical degree from Columbia University College of Physicians and Surgeons. He went on to complete his residency in internal medicine at St. Luke’s Hospital, followed by a fellowship in pulmonary medicine at Bellevue Hospital Center. Dr. Hamm has been named a Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly. He has also been named a Top MD by Consumers’ Checkbook Magazine. Dr. Hamm contributed to a publication on the diagnosis of pulmonary Kaposi’s sarcoma with fiberoptic bronchoscopy and endobronchial biopsy. Dr. Hamm is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. Dr. Hamm is board certified in American Board Of Internal Medicine.

Dr. Susan Scott is a thoracic medical oncologist with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital and Assistant Professor of Oncology at the Johns Hopkins University School of Medicine. Dr. Scott has expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and pulmonary carcinoid tumors, as well as thymic malignancies. She leads the EGFR and HER2 lung cancer research program for Johns Hopkins. Dr. Scott received her undergraduate education at the University of Oxford, UK and medical doctorate from Yale University. She completed residency at the Cleveland Clinic where she also served as Chief Resident in Internal Medicine. Dr. Scott joined Johns Hopkins Oncology for fellowship training in Baltimore and was recruited to the thoracic oncology program to continue work as a physician and clinical scientist focused in lung cancer. Dr. Scott and her team are committed to providing compassionate and individualized care to their patients, including state-of-the-art therapies and clinical trials. Her research interests include clinical trials in resectable lung cancer, innovative applications of immunotherapy, and novel targeted therapies, especially EGFR- and HER2-mutated lung cancers. Dr. Scott is a member of the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and the International Association for the Study of Lung Cancer (IASLC). Dr. Scott is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Cancer, and EGFR Positive Lung Cancer. Dr. Scott is board certified in American Board Of Internal Medicine.

Nam Nguyen is an Internal Medicine provider practicing medicine in Washington, Washington, D.c.. Dr. Nguyen is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Prostate Cancer, Familial Prostate Cancer, and Throat Cancer. Dr. Nguyen is currently accepting new patients.